Skip to main content
Clinical Trials/NCT05266885
NCT05266885
Completed
Not Applicable

Prevalence of Hypertension in Type-2 Diabetes Mellitus

Kabul University of Medical Sciences1 site in 1 country322 target enrollmentNovember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prevalence of Elevated Blood Pressure in Type-2 Diabetics
Sponsor
Kabul University of Medical Sciences
Enrollment
322
Locations
1
Primary Endpoint
High incidence of HTN in Diabetics
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

Detailed Description

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients. This is a descriptive cross-sectional study, which included 322 type -2 diabetic patients (37 male, 63 female) who were presented to our center from November 2019 to January 2020.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
January 30, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kabul University of Medical Sciences
Responsible Party
Principal Investigator
Principal Investigator

Habib Ahmad Esmat

Research committee

Kabul University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed diabetic patients
  • Newly diagnosed Diabetics
  • known case of diabetes

Exclusion Criteria

  • The patients who were seriously ill
  • Pregnant women
  • Type-1 diabetic patients,

Outcomes

Primary Outcomes

High incidence of HTN in Diabetics

Time Frame: 3 months

Study Sites (1)

Loading locations...

Similar Trials